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AbstrACt
background The effectiveness of health checks aimed 
at the general population is disputable. However, it is 
not clear whether health checks aimed at certain groups 
at high risk may reduce adverse health behaviour and 
identify persons with metabolic risk factors and non-
communicable diseases (NCDs).
Objectives To assess the effect of general practice-based 
health checks on health behaviour and incidence on NCDs 
in individuals with low socioeconomic position.
Methods Individuals with no formal education beyond 
lower secondary school and aged 45–64 years were 
randomly assigned to the intervention group of a 
preventive health check or to control group of usual care 
in a 1:1 allocation. Randomisation was stratified by gender 
and 5-year age group. Due to the real-life setting, blinding 
of participants was only possible in the control group. 
Effects were analysed as intention to treat (ITT) and per 
protocol. The trial was undertaken in 32 general practice 
units in Copenhagen, Denmark.
Intervention Invitation to a prescheduled preventive 
health check from the general practitioner (GP) followed by 
a health consultation and an offer of follow-up with health 
risk behaviour change or preventive medical treatment, if 
necessary.
Primary outcome measures Smoking status at 
12-month follow-up. Secondary outcomes included 
status in other health behaviours such as alcohol 
consumption, physical activity and body mass index 
(measured by self-administered questionnaire), as well 
as incidence of metabolic risk factors and NCDs such as 
hypertension, hypercholesterolaemia, chronic obstructive 
pulmonary disease, diabetes mellitus, hypothyroidism, 
hyperthyroidism and depression (drawn from national 
healthcare registries).
results 1104 participants were included in the study. For 
the primary outcome, 710 participants were included in 
the per protocol analysis, excluding individuals who did 
not attend the health check, and 1104 participants were 
included in the ITT analysis. At 12-month follow-up, 37% 
were daily smokers in the intervention group and 37% 
in the control group (ORs=0.99, 95% CI: 0.76 to 1.30). 
No difference in health behaviour nor in the incidence of 
metabolic risk factors and NCDs between the intervention 
and control group were found. Side effects were 
comparable across the two groups.
Conclusion The lack of effectiveness may be due to low 
intensity of intervention, a high prevalence of metabolic 
risk factors and NCDs among the participants at baseline 
as well as a high number of contacts with the GPs in 
general or to the fact that general practices are not an 
effective setting for prevention.
trial registration number NCT01979107.
strengths and limitations of this study
 ► A major strength of this study is that it is a large-
scale community-based health check intervention 
implemented in 32 general practice clinics and 
evaluated with long follow-up (1 year) and in a ran-
domised controlled design.
 ► The study targets both health behaviour chang-
es and detection of non-communicable diseases 
(NCDs) and combines both patient-reported and 
register-based outcomes.
 ► The patient-reported data were linked at the individ-
ual level with national health register and obtained 
information on NCDs, which ensured no loss to fol-
low-up regarding this outcome.
 ► The study focuses on individuals with low socio-
economic—an under-studied group in health check 
interventions.
 ► The limitations of this study include the lack of data 
on smoking status in non-respondents and no ac-
cess to primary care medical records with details on 
any condition not leading to hospital contact.  on O
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IntrOduCtIOn
There is a large body of evidence that developing 
non-communicable diseases (NCDs) is closely linked with 
modifiable health behaviours such as smoking, alcohol 
consumption, poor diet and physical inactivity as well as 
metabolic risk factors such as hypertension, lipid levels 
and blood glucose, and obesity.1 Furthermore, the occur-
rence of multiple of these adverse health behaviours is 
strongly associated with mortality2 but are difficult to 
modify.3 Health checks may identify individuals with 
adverse health behaviour and detect metabolic risk 
factors and NCDs at an early stage.4 To prevent NCDs or 
limit future harms from NCDs, health checks may provide 
an opportunity to motivate for behavioural change or to 
initiate appropriate preventive medical treatment. Bene-
fits of general preventive health checks are, however, 
disputed. One Cochrane review, which included 14 trials 
on general health checks (n=533–57 460), concluded 
that health checks offered to the general population did 
not reduce morbidity or mortality beyond that of usual 
care.5 Most of the included trials, however, took place 
20–30 years ago, prior to the introduction of much of 
the preventive medication in current use.6 A more recent 
meta-analysis, including six trials conducted in general 
practice (n=1442–7229), showed improvements in blood 
pressure, total cholesterol and body mass index (BMI), 
and reduced the proportion of patients remaining at high 
risk for NCDs.7 Among others, low socioeconomic posi-
tion (SEP) has been shown to be associated with non-par-
ticipation in health checks.5 8–11 Because of the lower 
participation among individuals of low SEP10 and a social 
gradient in modifiable adverse health behaviours and 
NCDs,1 12 13 it has been suggested that further research in 
the field of health check should put an extra effort into 
recruiting especially socioeconomically disadvantaged 
individuals.5 10
In Denmark, general practice and municipalities have 
a shared responsibility for preventive services aimed at 
the individual. General practitioners (GPs) assess patient 
health and implement disease-specific secondary preven-
tion, the municipalities are tasked with primary preven-
tion such as smoking cessation, alcohol treatment and 
other lifestyle-related services.14 GPs collaborate closely 
with municipal services and can refer to some services, 
for instance, lifestyle change programme at the munic-
ipality health centre.15 Visiting the GP is free of charge, 
and around 98% of the population is assigned to one 
specific GP.16
The ‘Check-In’ intervention was developed to test the 
effectiveness of a preventive health check in a randomised 
controlled trial (RCT) at general practice offered to indi-
viduals with low SEP as measured by short education. It 
was developed in response to health-behaviour models 
in which increased awareness about the causes, conse-
quences and cures for a particular health behaviour or 
health problem is expected to increase the likelihood 
for change17 and in which knowledge is expected to lead 
to action.18 A preventive health check at the GP has the 
potential to confront the patient with a problem and 
provide feedback about both adverse health behaviour 
and the consequences of continuing the injurious 
behaviour. For example, poor lung function measure can 
demonstrate the health consequences of smoking and 
lead to a discussion about the adverse effects of smoking 
which may increase the chance for smoking cessation.
Short education was used as measure for low SEP as 
educational level captures the influence of resources on 
health and the knowledge and skills attained through 
education may affect an individual’s cognitive func-
tioning, make individuals more receptive to health educa-
tion messages or more able to communicate with and 
access appropriate health services.19
We set out to test if ‘Check-In’ results in lower preva-
lence of adverse health behaviour such as smoking, exces-
sive alcohol consumption, physical inactivity and obesity, 
and to test if ‘Check-In’ results in more new hospital 
contacts and prescription medication for metabolic risk 
factors and NCDs such as hypertension, hypercholestero-
laemia, chronic obstructive pulmonary disease (COPD), 
diabetes mellitus, hypothyroidism, hyperthyroidism and 
depression. In this article, we report on the effects of 
‘Check-In’ at 12-month follow-up.
MethOds And MAterIAl
trial design
‘Check-In’ was a two-arm 1:1 RCT conducted in Copen-
hagen, Denmark from January 2014 to September 2016.
Identification of the study population
All 126 general practices in four different suburbs of 
Copenhagen, Denmark, were invited by letter and phone 
to participate in the study. The recruitment of the GPs 
was, however, challenged due to a break down in the 
collective bargaining between the Danish Regions Salary 
and Rate Board and the Organisation of General Practi-
tioners in late 2012.20 In all, ‘Check-In’ ended up having 
five rounds between January 2014 and September 2016.
GPs do not systematically register their patients’ educa-
tional level. Therefore, to identify the study population 
baseline questionnaires in Danish (including items about 
sex, date of birth, cohabitation status, highest educational 
level achieved, height and weight, smoking status, alcohol 
consumption, physical activity, diet, general self-efficacy, 
perceived stress and family disposition of NCDs) were 
sent out to all individuals aged 45–64 years, who lived 
in Copenhagen and who were on the participating GPs’ 
patient lists. The questionnaire was accompanied by a 
short letter from the GP and the research team describing 
that the questionnaire information would be entered into 
the electronic patient record at the GP, and thus could be 
used in future visits. Furthermore, it was explained that 
the questionnaire was part of a larger research project 
and that participation was voluntary and without negative 
consequences for the continuing doctor–patient relation-
ship. At the end of the questionnaire, individuals were 
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asked to indicate if they would consent to be contacted 
for participation in a future research project.
Eligible patients met the inclusion criteria which were 
no formal education beyond lower secondary school and 
consent to be contacted for research purpose. No exclu-
sion criteria were implied.
randomisation
Eligible patients were randomised in the Statistical Anal-
ysis Software by a data manager at the National Institute 
of Public Health to either ‘Check-In’ or usual care in a 1:1 
allocation. The randomisation was stratified by gender 
and 5-year age group. Couples living together were allo-
cated to the same group to avoid contamination.
Double-blinded, meaning that both patients and GPs 
were blinded to the allocation of group, would have been 
ideal21; nevertheless, due to real-life setting, blinding of 
participants was only possible in the control group and 
not in the intervention group and among GPs.
Interventions
‘Check-In’ group (intervention)
The intervention included (i) an invitation to a presched-
uled health check, (ii) a health check at the GP and (iii) 
a health consultation at the GP which included an offer 
of further action if necessary.
Invitation
All participants allocated to the intervention group 
received a postal invitation to a prescheduled health 
check from their GP and the research team. Included 
with the invitation was a written description of the project. 
Furthermore, it was clarified that study participation was 
voluntary and that withdrawal could occur at any time. 
Three days before the prescheduled appointment, partic-
ipants in the intervention group were reminded by phone 
by a member of the research team.
Health check
Before the health check, the GPs received results from 
the patient-reported questionnaire in the GPs electronic 
patient record in the form of an electronic data inter-
change message including summed scores and cate-
gorisation of items from the baseline questionnaire (see 
online supplementary file 1). The health check was free 
of charge and took place during the opening hour of the 
general practice clinic to which the patient was registered 
and was conducted by either the GP or other health staff at 
the clinic as per usual clinical practice. The health check 
consisted of measurements of weight and height, hip and 
waist circumference, cholesterol, glycated haemoglobin, 
thyroidal status and spirometry for smokers or former 
smokers. The health consultation with the purpose of 
review of results was scheduled at the health checks.
Health consultation
At the health consultation, the GP reviewed the results 
from the health check in combination with the summarised 
results of the questionnaire. Participants with abnormal 
screens, or health behaviour amenable to intervention 
at the health check, either follow the medical standards 
for general practice on procedures for diagnostics and 
treatment or received the offer of a referral to the munic-
ipality health centre for a lifestyle change programme. 
Furthermore, these participants were offered an addi-
tional health check scheduled 6 months after the first 
health check. Decisions for further action and reasons 
for referral or not were indicated by the GP in a project 
specified form.
Usual care (control)
Participants allocated to the control group received 
unrestricted usual care during the intervention period. 
The results from the questionnaires were entered in the 
GPs electronic patient record; however, no feedback was 
provided to the patients.
Measurement of health behaviour
Health behaviour was measured from a self-administrated 
questionnaire at baseline and at 12-month follow-up. The 
questionnaire contained information about sociodemo-
graphic characteristics (education level and cohabitation 
status), health-related quality of life (12-Item Short Form 
Health Survey),22 23 height and weight, smoking status, 
alcohol consumption, physical activity, diet, pulmonary 
symptoms, family dispositions of chronic diseases, general 
self-efficacy24 25 and stress (measured by Cohen’s 10-item 
Perceived Stress Scale (PSS)).26
The primary outcome was self-reported smoking status 
at 12-month follow-up. Questions included ‘Do you 
smoke?’, with the response categories ‘yes, daily’, ‘yes, I 
smoke occasional’, ‘no, I stopped less than 6 months ago’, 
‘no, I stopped more than 6 months ago’, ‘no, I have never 
smoked’; dichotomised into ‘daily smokers’ versus ‘not 
daily smokers’ and ‘How much do you approximately 
smoke each day?’ used as continuous outcome.
Secondary outcomes included self-reported alcohol 
consumption, physical activity, BMI, self-efficacy and 
perceived stress. Alcohol consumption was measured as 
binge drinking (five or more units of alcohol on the same 
occasion) dichotomised into ‘weekly or more frequent’ 
versus ‘less than weekly’, and units of alcohol each day 
during the week used as a continuous outcome. Phys-
ical activity was measured from two questions on hours 
spend on exercise ‘making you short of breath’ during 
the week and everyday exercise, dichotomised into phys-
ical inactivity (yes, no), ‘yes’ defined as less than 150 min 
of moderate-intensity physical activity throughout the 
week, less than 75 min of vigorous-intensity physical 
activity throughout the week or an equivalent combina-
tion of moderate-intensity and vigorous-intensity activity 
and ‘no’ defined as more, as defined by WHO.27 BMI was 
generated from questions about height and weight and 
analysed as a dichotomised outcome into obese yes/no, 
‘yes’ defined as BMI ≥30 and ‘no’ defined as BMI <3028 
and as a continuous outcome (see online supplementary 
file 2). Stress during the past month was assessed by the 
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PSS (score range 0–40).26 The person’s belief in their 
innate ability to achieve goals was assessed using general 
self-efficacy (score range 10–40).25 29
Measurement of metabolic risk factors and nCds
Metabolic risk factors and NCDs were measured as any 
hospital contact and/or prescription medication for hyper-
tension, hypercholesterolaemia, COPD, diabetes mellitus, 
thyroid disease and depression in the follow-up period. 
International Classification of Diseases, 10th revision codes 
and Anatomical Therapeutic Chemical Classification codes 
were specified for each of the conditions. The algorithm in 
the supplementary files gives an overview of the used defini-
tions (see online supplementary file 3).
All citizens with a permanent residence in Denmark have 
a unique personal identification number, which makes it 
possible to link individual information from surveys to 
nation-wide administrative registries.30 For information 
about hospital contacts and discharge diagnoses, we linked 
to the Danish National Patient Register.31 The Danish 
National Prescription Registry32 was used to obtain infor-
mation on dispensed prescription medications.
To ensure that only new contacts and/or prescrip-
tion medication of metabolic risk factors and NCDs were 
included in the incidence analysis, register-based data on 
metabolic risk factors and NCDs were collected for a period 
of 15 years for diagnosis and 2 years for prescription medi-
cation before the baseline questionnaire were sent.
Furthermore, information on date of death was 
extracted from the Danish Register of Causes of Death.33 
The Danish National Health Services Register was used 
for information on contacts with the general practice.16
sample size consideration
The number of individuals to include in the ‘Check-In’ 
and usual care group were determined prior to data 
collection. Sample size calculation was performed to test 
the difference between two proportions.34 We expected a 
participation rate of 75% for the health check. Based on 
prevalence from the Danish National Health Survey from 
2010, a daily smoking prevalence of 41% was assumed in 
the 45-year to 64-year-old individuals with basic educa-
tion; of these we expected that 50% were motivated 
to quit smoking.35 High-standard smoking cessation 
courses have been shown to yield a cessation prevalence 
of 20%–30%.36 In the usual care group, we expected a 
cessation prevalence of 5%. Thus, we needed 150 daily 
smokers in each arm to detect a difference in quit rates of 
15% with 80% power.
statistical analysis
To compare health behaviour at 12-month follow-up in 
the ‘Check-In’ and usual care group, logistic regression 
modelling estimated intervention effectiveness on the 
binary outcomes daily smoking, binge drinking, obesity 
and physical inactivity. The model included the condition 
variable (‘Check-In’ vs usual care). For the continuous 
outcomes, cigarettes per day (among daily smokers), 
drinks per week (among those who drink alcohol) and 
BMI, median and IQR were estimated.
The analyses were performed (i) per protocol, excluding 
individuals who did not attend the health check and (ii) 
intention to treat (ITT). ITT analyses are recommended 
in the Consolidated Standards of Reporting Trials state-
ment37 and implies that all randomised individuals 
are included in the analysis regardless of whether they 
attended the prescheduled health check or not. For the 
ITT analyses, we estimated missing data using multiple 
imputation.38 The imputation process for each outcome 
utilised participant’s sex, age, ethnicity, cohabitant and 
employment status, condition variable and baseline 
specific variable. Twenty imputations were undertaken for 
each imputation, estimate and pooled results from these 
were used. In general, missing at specific item responses 
was low at baseline (less than 5%)—except for drinks per 
week (7% missing) and self-efficacy (6% missing) (data not 
shown). Final levels of missing data on primary outcome 
were 1% at baseline and 25% at 12- month follow-up. 
Missing at follow-up was primary due to non-response.
To compare metabolic risk factors and NCDs at 
12-month follow-up in the ‘Check-In’ and usual care 
group logistics regression were conducted for each of the 
outcomes hypertension, hypercholesterolaemia, COPD, 
diabetes mellitus, hypothyroidism and hyperthyroidism. 
Furthermore, the analyses were conducted for Any new 
chronic condition, defined as ‘yes’ if any new metabolic or 
NCDs were found in the follow-up period.
The analyses were performed both regarding all 
contacts/prescription medication (prevalence) and first 
contacts/prescriptions for metabolic risk factors and 
NCDs (incidence). The prevalence analysis included all 
individuals who had contact with the hospital and/or 
prescription medication for the metabolic risk factors 
and NCDs in the 12-month follow-up period. The inci-
dence analyses excluded individuals who already had the 
specific metabolic risk factor or NCD at baseline. Infor-
mation on metabolic risk factors and NCDs were obtained 
from registers and no missing occurred in these variables.
To evaluate the stability of our results, an interclass 
coefficient (ICC) was estimated within a two-level model 
with patients (level 1) nested within general practices 
(level 2), and all estimates were calculated in the model 
including the condition variable and general practices 
as random intercept, allowing for correlation between 
patients from the same general practice.39 Furthermore, 
sensitivity analysis including age and sex in the logistic 
regression were carried out.
Patient and public involvement
Patients were not formally involved in the development of 
the trial. The ‘Check-In’ intervention was, however, devel-
oped in close integration with GPs. Before ‘Check-In’ was 
rolled out in the bigger scale, the feasibility of the inter-
vention was tested in a pilot study. In the pilot study, the 
questionnaire was tested among the target group by inter-
viewing them after they filled it in and non-responders 
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Figure 1 ConsolidatedStandards of Reporting Trials flow diagram showing recruitment of general practices and patients 
in Check-In. #In the per protocol analyses are only included individuals who responded the questionnaire and who followed 
the ‘treatment’ for the allocated group (for individuals allocated to intervention, this meant attending the health check and 
responding to the questionnaire; for individuals allocated to usual care, this meant responding to the questionnaire). Hence, 
of the 425 responders in the intervention group, 303 individuals attended the health check and could be included in the per 
protocol analyse. Of the 422 responders in the usual care group, 407 answered the questions regarding the smoking status and 
could be included in the per protocol analyse.
were contacted by phone to include their experiences 
and reasons to not answer. Participants will not be directly 
contacted with results. All findings, including null find-
ings will be communicated to the public by use of press 
releases and a report in lay-language.
results
Participant flow
Of the 126 general practices invited, 32 clinics, including 
56 GPs, agreed to participate (clinic level participation 
25%). Figure 1 shows the flow diagram of ‘Check-In’. In 
total, 17 063 patients were mailed a baseline questionnaire. 
Of the 8508 (49%) who responded to the baseline ques-
tionnaire, 1104 met the inclusion criteria regarding level 
of education and marked that they could be contacted 
again (range per general practice clinic: 12–110 indi-
viduals; median=18). Of the 1104 participants, 549 
were randomised to the ‘Check-In’ group and invited 
to the prescheduled health check, which 364 attended 
(attendance rate of 66%). Of the 1104 participants, 850 
completed the follow-up questionnaire at 12 months 
(response rate of 77%). The number analysed for the 
‘per protocol’ depended on the specific outcome—for 
the primary outcome daily smoking, this was 710, 303 for 
 on O
ctober 24, 2019 by guest. P
rotected by copyright.
http://bm
jopen.bm
j.com
/
B
M
J O
pen: first published as 10.1136/bm
jopen-2019-029180 on 18 S
eptem
ber 2019. D
ow
nloaded from
 
6 Kamstrup-Larsen N, et al. BMJ Open 2019;9:e029180. doi:10.1136/bmjopen-2019-029180
Open access 
the ‘Check-In’ group and 407 for the usual care group. 
For the ITT analyses, the number of analysed equal the 
number allocated to ‘Check-In’ and usual care group, 
respectively (figure 1).
baseline characteristics
Table 1 shows the baseline characteristics for the 
‘Check-In’ and usual care group. The average age was 
54 years, about half were men and more than 40% were 
unemployed or on social security. About 41% reported 
daily smoking and 17% in the ‘Check-In’ group and 20% 
in the usual care group reported ‘binge drinking at least 
weekly’. Median BMI was 26, with 20% obese in ‘Check-In’ 
group and 23% in usual care group at baseline. Overall, 
61% in the ‘Check-In’ and 65% in the usual care group, 
respectively, had at least one NCD and 18% had ≥3 NCDs 
in the two groups. Around 88% had contact with their GP 
within the last year. The baseline characteristics were well 
balanced between the ‘Check-In’ and usual care group 
(table 1).
effectiveness of ‘Check-In’ on daily smoking and other health 
behaviour
After 12 months of follow-up, no difference was found 
between the ‘Check-In’ and usual care group on daily 
smoking (ITT: ORs=0.99; 95% CI: 0.76 to 1.30), binge 
drinking (ITT: OR=0.82; 95% CI: 0.59 to 1.14), physical 
inactivity (ITT: OR=0.97; 95% CI: 0.74 to 1.27) or obesity 
(ITT: OR=0.90; 95% CI: 0.67 to 1.21) (table 2)—this 
was seen in both the per protocol and ITT analysis. No 
differences were found for comparison of number of 
cigarettes/day (ITT: Coefficient (coef.)=0; 95% CI: −2.9 
to 2.9)), units of alcohol/day (ITT: coef.=0; 95% CI: 
−1.7 to 1.8) and BMI (ITT: coef.=−0.5; 95% CI: −1.2 to 
0.1) (table 3) indicating no effect of ‘Check-In’ on daily 
smoking or other health behaviour. Furthermore, no 
difference between the two groups were found regarding 
self-efficacy where both groups had a median at 29 (IQR 
for ‘Check-In’ 25,33; IQR for usual care 24,34) (data not 
shown).
effectiveness of ‘Check-In’ on detection of metabolic risk 
factors and nCds
At 12-month follow-up, we found a difference in incidence 
of depression in the ‘Check-In’ group when compared 
with usual care (OR=2.90; 95% CI: 1.34 to 6.29) and a 
tendency for COPD (OR=1.44; 95% CI: 0.83 to 2.50) 
(table 4). No differences between the ‘Check-In’ and 
usual care groups were observed for incidence in hyper-
tension, hypercholesterolaemia and diabetes mellitus. 
The estimates for hypothyroidism and hyperthyroidism 
have not been reported for ethical reasons as there were 
too few cases to report (table 4).
We found no differences between the Check-In and 
the usual care group in prevalence of hypertension, 
hypercholesterolaemia, COPD, diabetes mellitus, hypo-
thyroidism, hyperthyroidism or depression (see online 
supplementary file 4)—this was seen in both the per 
protocol and ITT analysis.
stability of our results and sensitivity analysis
The ICC was low (ICC=0.008) indicating that patients 
within the same general practice were not clustered, and 
all estimates from multi-level analyses (data not shown) 
showed no different in estimates compared with estimates 
from logistics regression. The adjusted sensitivity analysis 
did not affect the estimates (data not shown). In addition, 
the baseline characteristics for those lost to follow-up and 
those not lost to follow-up were comparable; however, the 
proportion of daily smokers and physical inactive were 
higher among those lost to follow-up compared with 
those not lost to follow-up (see online supplementary file 
5).
Potential side effects
To evaluate potential side effects of ‘Check-In’, we anal-
ysed perceived level of stress for the ‘Check-In’ and usual 
care group at 12-month follow-up. We found no difference 
between the two groups; both groups had a median at 16 
on the perceived level of stress scale (IQR for ‘Check-In’ 
11,20; IQR for usual care 11,21) (data not shown).
dIsCussIOn
In this RCT, we found no effect of an intervention of GPs 
invited individuals with low SEP to a prescheduled preven-
tive health check. We found no differences in smoking 
status, alcohol consumption, physical inactivity, BMI or 
in the prevalence of metabolic risk factors and NCDs at 
12-month follow-up between the ‘Check-In’ group and 
usual care group. We did, however, find a difference in 
incidence of depression, as measured by first prescription 
of antidepressant medication between the ‘Check-In’ and 
the usual care group at 12-month follow-up.
The baseline characteristics showed that more than 
40% of the participants were daily smokers (table 1) as 
compared with 17% in the general Danish population.40 
This indicated that we did reach a group with a more 
adverse health behaviour profile than the general popula-
tion. However, the intensity of the intervention might have 
been too low to achieve sufficient change of adverse health 
behaviour among individuals with low SEP, which may have 
contributed to the lack of measurable behavioural change 
in ‘Check-In’. In a previous Danish study of health checks, 
a significant higher smoking abstinence rate was found in 
a high-intensity intervention group compared with usual 
care.41 The high-intensity intervention included a consul-
tation based on motivational interviewing, complementary 
samples of nicotine products, a self-help pamphlet and 
the offer of participation in six smoking cessation group 
counselling sessions over a period of 5 months.41 More-
over, higher SEP was a predictor of successful smoking 
cessation.41 In contrast, ‘Check-In’ relied on the behaviour 
change services offered by the municipality since 2007.15 42 
The idea in ‘Check-In’ was that patients with adverse health 
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Table 1 Baseline characteristics for participants with low socioeconomic position allocated to a preventive health check at 
the general practitioner (‘Check-In’) or to usual care
‘Check-In’ group (n=549) Usual care group (n=555)
Demographic and socioeconomic characteristics
  Age, years (median (IQR2; IQR3)) 54 (49; 59) 54 (49; 59)
  Men 282 (51) 293 (53)
  Danish/other Western ethnic background 437 (79) 446 (81)
  Married/cohabitant 279 (51) 270 (49)
  Children living at home 137 (25) 134 (24)
  Employment status
   Employed 269 (49) 266 (48)
   Unemployed/social security 224 (41) 239 (43)
   Retired/other 56 (10) 49 (9)
Health behaviour
  Cigarette smoking
   Daily smoker 228 (42) 225 (41)
   Not daily smoker 312 (58) 326 (59)
  Cigarettes/day*, (median (IQR2; IQR3)) 18 (10; 20) 20 (10; 20)
  Current non-drinkers 171 (32) 174 (32)
  Drinks/week†, (median (IQR2; IQR3)) 6 (3; 15) 6 (2; 16)
  Binge drinking at least weekly 94 (17) 110 (20)
  Physical inactivity‡ 268 (49) 286 (52)
  BMI (kg/m2), (median (IQR2; IQR3)) 25.9 (23.1; 29.1) 26.2 (23.4; 29.7)
  Obese (BMI ≥30 kg/m2) 104 (20) 124 (23)
  Self-rated bad to very bad health 213 (39) 225 (41)
  Self-efficacy, (median (IQR2; IQR3)) 29 (24; 33) 29 (24; 33)
Morbidity and contact with GP
  Non-communicable diseases
   Any chronic condition 337 (61) 359 (65)
   Hypertension 118 (22) 133 (24)
   Hypercholesterolaemia 97 (18) 99 (18)
   COPD 124 (23) 127 (23)
   Diabetes mellitus 175 (32) 191 (34)
   Hypothyroidism 55 (10) 44 (8)
   Hyperthyroidism 24 (4) 22 (4)
   Depression 79 (15) 81 (15)
  Number of non-communicable diseases
   0 212 (39) 196 (35)
   1 147 (27) 149 (27)
   2 93 (17) 112 (20)
   ≥3 97 (18) 98 (18)
  Contact with GP within the last year 495 (90) 480 (87)
  Number of contacts with the GP within the last year§, (median (IQR2; 
IQR3))
7 (4; 13) 8 (4; 14)
Values are number (percentages) unless stated otherwise.
*Among daily smokers.
†Among those who drink alcohol.
‡Less than 150 min of moderate-intensity physical activity.
§Among those who visit their GP within the last year.
COPD, chronic obstructive pulmonary disease; GP, General practitioner.
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Table 2 Effectiveness of ‘Check-In’ on smoking status (primary outcome) and other health behaviour at 12-month follow-up 
measured as dichotomised outcomes
Dichotomies outcomes
n (%) Effectiveness (‘Check-In’ vs usual care)
‘Check-In’ group 
(n=549)
Usual care group 
(n=555) OR (95% CI) P value
Primary outcome
  Daily smokers
   Per protocol, n=710 94 (31) 147 (36) 0.80 (0.58 to 1.09) 0.16
   ITT; multiple imputation 203 (37) 205 (37) 0.99 (0.76 to 1.30) 0.95
Secondary outcomes
  Binge drinking ≥weekly
   Per protocol, n=718 55 (18) 84 (20) 0.87 (0.60 to 1.27) 0.48
   ITT; multiple imputation 98 (18) 116 (21) 0.82 (0.59 to 1.14) 0.24
  Physical inactivity (<150 min/week)
   Per protocol, n=721 132 (43) 186 (45) 0.92 (0.68 to 1.23) 0.56
   ITT; multiple imputation 252 (46) 260 (47) 0.97 (0.74 to 1.27) 0.84
  Obese (BMI ≥30 kg/m2)
   Per protocol, n=684 68 (23) 90 (23) 1.01 (0.71 to 1.45) 0.95
   ITT; multiple imputation 131 (24) 122 (22) 0.90 (0.67 to 1.21) 0.93
Values are number (percentages), ORs and p values for the intervention effectiveness. The analyses are performed as per protocol and ITT 
with multiple imputation.
BMI, body mass index; ITT, intention to treat.
Table 3 Effectiveness of ‘Check-In’ on health behaviour measured as continuous outcomes at 12-month follow-up measured 
as continuous outcomes
Continuous outcomes
Median (IQR2;IQR3)
Effectiveness (‘Check-
In’ vs usual care) P value
‘Check-In’ group 
(n=549)
Usual care group 
(n=555) Coef. (95% CI)
Median 
regression*
Cigarettes/day†
  Per protocol, n=239 17 (14; 20) 15 (10; 20) 2 (−4.7 to 8.7) 0.35
  ITT; multiple imputation 15 (7; 20) 15 (7; 20) 0 (−2.9 to 2.9) 0.99
Drinks/week‡
  Per protocol, n=419 7 (4; 19) 8 (4; 17) −1 (−2.8 to 0.8) 0.38
  ITT; multiple imputation 7 (4; 17) 7 (4; 15) 0 (−1.7 to 1.8) 0.95
BMI
  Per protocol, n=684 25.9 (23.5; 29.7) 26.4 (23.8; 29.6) −0.5 (−1.2 to 0.2) 0.19
  ITT; multiple imputation 25.9 (23.2; 29.4) 26.4 (23.6 :29.8) −0.5 (−1.2 to 0.1) 0.11
The analyses are performed as per protocol and ITT with multiple imputation.
*Median regression estimates the median of the dependent variable.
†Among daily smokers.
‡Among those who drink alcohol.
BMI, body mass index; ITT, intention to treat.
behaviour amenable to intervention at the health check 
should be offered a referral to the municipality health 
centre for a free lifestyle change programme. However, 
project data indicated that the opportunity of a referral 
may have been under-utilised as some of the patients 
rejected a referral to the municipality, and in some cases, 
the GP considered a referral to be irrelevant. The result 
was a low level of intensity of the part of the intervention 
targeting adverse health behaviour.
Our results are, however, in line with the results from 
another study focusing at patients with high risk of 
cardiovascular disease, as they found no differences in 
the proportion of non-smoking among patients in the 
intervention compared with usual-care group.43
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Table 4 Effectiveness of ‘Check-In’ on incidence of COPD, diabetes mellitus, disorder of the thyroid gland, hypertension and 
hypercholesterolaemia
n (%) Effectiveness (‘Check-In’ vs Usual care)
‘Check-In’ group Usual care group OR (95% CI) P value
Any new chronic condition*
  Per protocol, n=919 82 (23) 120 (22) 1.05 (0.77 to 1.45) 0.75
  ITT, n=1104 125 (23) 120 (22) 1.07 (0.80 to 1.42) 0.65
Hypertension
  Per protocol, n=704 40 (14) 60 (14) 1.01 (0.66 to 1.56) 0.96
  ITT, n=856 55 (13) 60 (14) 0.88 (0.60 to 1.31) 0.54
Hypercholesterolaemia
  Per protocol, n=752 13 (4) 20 (4) 1.00 (0.49 to 2.05) 0.99
  ITT, n=908 18 (4) 20 (4) 0.90 (0.47 to 1.73) 0.76
COPD
  Per protocol, n=711 19 (7) 23 (5) 1.24 (0.66 to 2.31) 0.51
  ITT, n=844 32 (8) 23 (5) 1.44 (0.83 to 2.50) 0.2
Diabetes mellitus
  Per protocol, n=604 8 (3) 15 (4) 0.74 (0.31 to 1.76) 0.49
  ITT, n=720 14 (4) 15 (4) 0.89 (0.42 to 1.87) 0.76
Hypothyroidism†
  Per protocol, n=919 – – – –
  ITT, n=840 – – – –
Hyperthyroidism†
  Per protocol, n=878 – – – –
  ITT, n=1051 – – – –
Depression
  Per protocol, n=789 12 (4) 9 (2) 2.05 (0.85 to 4.91) 0.11
  ITT, n=944 25 (5) 9 (2) 2.90 (1.34 to 6.29) 0.007
The analyses are performed per protocol and as ITT.
*Hypertension if no hypertension at baseline, hypercholesterolaemia if no hypercholesterolaemia at baseline, COPD if no COPD at baseline, 
diabetes if no diabetes at baseline, hypothyroidism if no hypothyroidism at baseline, hyperthyroidism if no hyperthyroidism at baseline or 
depression if no depression at baseline.
†Too few in each group to report for ethical reasons.
COPD, chronic obstructive pulmonary disease; ITT, intention to treat.
The lack of effectiveness of ‘Check-In’ regarding more 
new hospital contacts and prescription medication for 
metabolic risk factors and NCDs can be ascribed to the 
fact that more than 60% of individuals included in the 
study were known with one or more NCDs at baseline. 
Most had visited their GP within the last year with a 
median number of contacts to the GP of 7 and 8 in the 
‘Check-In’ and usual care group, respectively (table 1). 
Patients with a known NCD may, as such most likely, 
already be in some kind of scheduled treatment at their 
GP. This illustrates that in terms of health, it is indeed 
a high-risk group participating in ‘Check-In’, but the 
intervention may not in absolute numbers have picked 
up many individuals undiagnosed with metabolic risk 
factors or NCDs, although we did see that there were 
more persons who initiated treatment with antidepres-
sants in the ‘Check-In’ group compared with the usual 
care group. This is in line with another Danish study.44 
Even so, we cannot completely rule out that the effective-
ness regarding depression was due to chance because of 
the small sample size in ‘Check-In’.
strengths and weaknesses
One strength of the study was that the randomisation 
resulted in two balanced groups at baseline and mini-
mised the influence of known and unknown confounding 
in the comparison of the ‘Check-In’ and the usual care 
group. Another strength was the use of both patient-re-
ported outcomes and register-based outcomes, where the 
use of register-based data allowed us to follow all individ-
uals in the study independent of attendance and respond 
to follow-up questionnaire. A third strength in ‘Check-In’ 
was the real-life setting, where the health checks were 
carried out at the general practice clinics to which the 
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patients were registered. Previous trials testing the effec-
tiveness of preventive health check have been criticised 
for designing a special unit to deliver the health check.6 
In ‘Check-In’, it was an assumption that GPs may be in a 
better position to deliver preventive health services than 
other health professionals and can offer professional 
advice accounting for the patients’ state of health in 
order to encourage compliance.45
A potential limitation in the study was contamination 
between groups, which potentially occurred if patients in 
the usual care group had treatment beyond usual care, 
for example, a health check in the intervention period or 
if GPs because of the project had more awareness of the 
preventive work such as smoking cessation when seeing 
patients allocated to usual care regarding other health 
issues. However, the risk of contamination is low because 
GPs did not know who were allocated to the usual care 
group and couples living together were allocated to same 
group. If contamination had occurred, the observed effec-
tiveness of the intervention is most likely conservative. 
Another limitation is the lack of data on smoking status 
in non-respondents and that we had no access to GP chart 
notes—any condition not leading to hospital contact are 
not registered. However, our inclusion of prescription 
medication should ensure the capture of conditions only 
managed in general practice.
Furthermore, our sample calculations were based on 
several assumptions which can be discussed. The assump-
tion that half are motivated to quit smoking can seem 
high and cannot be verified in the design. This assump-
tion is, however, supported by the literature where 63% 
of daily smokers in Denmark with no education beyond 
lower secondary school are found to be motivated to quit 
smoking.40 Moreover, the 10% a priori loss to follow-up 
was conservative when compared with the fact that the 
actually loss was 24%. Nevertheless, in total, 228 and 225 
daily smokers were enrolled in the ‘Check-In’ interven-
tion and control group, respectively, which exceeded the 
sample size calculations that indicated that we needed 
150 daily smokers in each group. This indicates that 
despite a higher loss to follow-up than expected the 
sample was most likely large enough to detect had there 
been any effect of ‘Check-In’ regarding adverse health 
behaviour. It can be argued that the GPs who partici-
pated in ‘Check-In’ were especially motivated; hence, if 
no effect on health behaviour and detection of metabolic 
risk factors and NCDs are found with these GPs it is plau-
sible to say that no effect will be found if the intervention 
were rolled out to all GPs. However, further studies are 
needed to understand non-participants and to under-
stand the process after a preventive health at the GP.
COnClusIOn
This study suggests that a systematic offer of a preventive 
health check at the general practice aimed at individuals 
with low SEP has no effect on adverse health behaviour 
or incidence on metabolic risk factors or NCDs compared 
with usual care. The explanations can be low inten-
sity of intervention, a high prevalence of metabolic risk 
factors and NCDs among the participants at baseline, a 
high number of contacts with the GP in general or that 
general practices are not an effective setting for primary 
prevention.
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